Our functional studies demonstrated that depletion of GM-CSF in TAMs or CSF2RA in cancer cells impairs EMT, migration, and invasion of breast cancer cells, and reduces brain metastatic tumor progression in vivo. This evidence concerns the gene CSF2 and breast carcinoma.